Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05280093 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

HEAL-IST IDE Trial

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv17
  2. Primary completion date: Jun 2026 to Feb 2027
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 26 to 27
    • Study completion date: Jun 2027 to Feb 2028
    v16
  3. Site details revised at 3 of 26 sitesv15
  4. Study sites: 23 to 26v14
  5. Study sites: 22 to 23v13
Show 11 earlier versionsHide 11 earlier versions
  1. Study sites: 18 to 22v12
  2. Study sites: 16 to 18v11
  3. Study sites: 15 to 16v10
  4. Study sites: 12 to 15v9
  5. Study sites: 10 to 12v8
  6. Trial status: Enrolling by Invitation to Recruiting
    • Site details revised at 10 of 10 sites
    v7
  7. Study sites: 9 to 10v6
  8. Study sites: 3 to 9v5
  9. Study sites: 2 to 3v4
  10. Study sites: 1 to 2v3
  11. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 2022 to May 31, 2022
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
AtriCure, Inc.
9 trials monitored
See 1 trial at risk
Inappropriate Sinus Tachycardia (IST) is a prevalent and debilitating condition in otherwise healthy younger patients, resulting in significant loss of quality of life, lacking effective treatment options or systematic clinical evidence to support a therapy. The primary objective of this clinical trial is to evaluate the safety and effectiveness of a hybrid sinus node sparing ablation procedure for the treatment of symptomatic drug refractory or drug intolerant IST.
Trial Details
NCT Number NCT05280093
Lead Sponsor AtriCure, Inc.
Conditions
(from sponsor)		 Inappropriate Sinus Tachycardia
Enrollment 142 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov